Larimar Therapeutics (LRMR)
(Delayed Data from NSDQ)
$7.24 USD
-0.24 (-3.21%)
Updated Sep 12, 2024 03:59 PM ET
After-Market: $7.26 +0.02 (0.28%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -0.34 |
Last EPS Surprise | -6.25% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.40 |
Next Year | -2.50 |
EPS (TTM) | -1.12 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.40 | -1.40 | -2.50 |
# of Estimates | 3 | 3 | 3 | 2 |
Most Recent Consensus | -0.41 | -0.46 | -1.50 | -2.50 |
High Estimate | -0.29 | -0.29 | -1.20 | -2.26 |
Low Estimate | -0.42 | -0.46 | -1.51 | -2.73 |
Year ago EPS | -0.21 | -0.30 | -0.84 | -1.40 |
Year over Year Growth Est. | -76.19% | -33.33% | -66.67% | -78.45% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.40 | -1.40 | -2.50 |
7 Days Ago | -0.37 | -0.40 | -1.40 | -2.50 |
30 Days Ago | -0.37 | -0.40 | -1.40 | -2.50 |
60 Days Ago | -0.33 | -0.37 | -1.29 | -2.22 |
90 Days Ago | -0.33 | -0.37 | -1.29 | -2.22 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.37 | -0.40 | -1.40 | -2.50 |
Zacks Consensus Estimate | -0.37 | -0.40 | -1.40 | -2.50 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.34 | -0.27 | -0.30 | -0.21 | NA |
Estimate | -0.32 | -0.24 | -0.25 | -0.23 | NA |
Difference | -0.02 | -0.03 | -0.05 | 0.02 | -0.02 |
Surprise | -6.25% | -12.50% | -20.00% | 8.70% | -7.51% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more